Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in Japan

  • 📰 Reuters
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Pfizer Inc and BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the coronavirus.

FILE PHOTO: A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegriand BioNTech SE announced on Tuesday the start in Japan of combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against the coronavirus.

The study will recruit 160 people aged 20 to 85, the companies said in a statement. They had earlier agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer Reportedly Manufactures ‘Several Hundred Thousand’ Covid-19 Vaccines Anticipating November Regulatory ApprovalI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com Why are titles so misleading I’m trying to start a new trend... when big media companies post click bait headlines: then we unsubscribe from them - enough for profit manufactured “journalism” ... fakenews
Source: Forbes - 🏆 394. / 53 Read more »

Serum Institute, Bharat Biotech to begin trial of intranasal COVID-19 vaccine soon: VardhanSerum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health Minister Dr Harsh Vardhan said on Sunday. The world will be great again A must watch, documentary about trump administration handle COVID-19.. available now on Amazon.. TOTALLY UNDER CONTROL Trailer (2020) Coronavirus, President Trump .. Vaccine from India Fuck thattttt
Source: Reuters - 🏆 2. / 97 Read more »

Newsom says California will review FDA-approved COVID-19 vaccines before releasing them to publicGov. Newsom added to concerns about COVID-19 vaccines and said the state will review the safety of any vaccine approved by the Trump administration.
Source: L.A. Times Health - 🏆 364. / 59 Read more »

Pfizer Reportedly Manufactures ‘Several Hundred Thousand’ Covid-19 Vaccines Anticipating November Regulatory ApprovalI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com Why are titles so misleading I’m trying to start a new trend... when big media companies post click bait headlines: then we unsubscribe from them - enough for profit manufactured “journalism” ... fakenews
Source: Forbes - 🏆 394. / 53 Read more »

Healthcare workers, high-risk people will get priority for COVID-19 vaccine in New York: governorNew York Governor Andrew Cuomo said on Sunday that healthcare workers and high-risk populations, including some long-term care residents, would get priority in his state to receive a COVID-19 vaccine when one is approved and available. 🤣🤣🤣🤣🤣🤣🤣🤣🤣 Correction: high-rich people will continue their priority... Nope!
Source: Reuters - 🏆 2. / 97 Read more »

UNICEF To Stockpile Over Half A Billion Syringes For Future COVID-19 VaccineThe agency, also known as the United Nations Children's Fund, plans to distribute up to 1 billion syringes by 2021.
Source: NPRHealth - 🏆 144. / 63 Read more »